Capital Contribution Consent Agreement

Recorded: 2009-03-31 Received: 2009-03-31 Pages: 7

Assignor

PGXHEALTH HOLDING, INC.

Executed: 2008-12-12

Assignee

PGXHEALTH, LLC

ONE GATEWAY CENTER, SUITE 702, NEWTON, MA, 02458, UNITED STATES

Covered Properties (13)

Polymorphisms in the human gene for OCT1 and their use in diagnostic applications

Application: 12/221,241 →

Polymorphisms in the human genes for OCT 1 and their use in diagnostic and therapeutic applications

Application: 12/221,130 →

Polymorphisms in the Human Gene for the Multidrug Resistance-Associated Protein 1 (Mrp-1) and Their Use in Diagnostic and Therapeutic Applications

Application: 11/901,238 →

Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications

Application: 10/525,360 →

Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications

Application: 10/503,078 →

Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications

Application: 10/965,348 →

Polymorphisms in the Human Gene for Cytochrome P450 Polypeptide 2C8 and Their Use in Diagnostic Applications

Application: 10/479,225 →

Polymorphisms in the human gene for CYP2D6 and their use in diagnostic and therapeutic applications

Application: 10/635,780 →

Polymorphisms in the Human CYP2D6 Gene Promoter Region and Their Use in Diagnostic and Therapeutic Applications

Application: 10/182,977 →

Polymorphisms in the Human Hpxr Gene and Their Use Diagnostic and Therapeutic Applications

Application: 10/070,588 →

Polymorphisms in the Human CYP3A4 and CYP3A7 Genes and Their Use in Diagnostic and Therapeutic Applications

Application: 10/070,587 →

Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications

Application: 09/958,635 →

Method for Detecting the Presence of at Least One Single Allele of a Deletion Mutant

Application: 09/791,105 →